Seoul
South Korea
10
2023-03-30
10
2024-09-17
These are the the leading inventors for applications assigned to ABCLON INC.:
ABCLON INC. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Antibody or antigen binding fragment thereof for specifically recognizing B cell malignancy, chimeric antigen receptor comprising same and use thereof
#2 | 2022-10-06 ✅ Patent 12,414,998 granted on 2025-09-16ANTI-HER2 AFFIBODY AND SWITCHABLE CHIMERIC ANTIGEN RECEPTOR USING SAME AS SWITCH MOLECULE
#3 | 2021-05-06 ✅ Patent 11,945,878 granted on 2024-04-02Switch molecule and switchable chimeric antigen receptor
#4 | 2021-04-29 ✅ Patent 12,624,099 granted on 2026-05-12POLYPEPTIDE IMPROVED IN PROTEIN PURITY AND AFFINITY FOR ANTIGEN, CONJUGATE THEREOF WITH ANTIBODY OR ANTIGEN-BINDING FRAGMENT, AND PREPARATION METHOD THEREFOR
#5 | 2021-03-04 ✅ Patent 11,708,409 granted on 2023-07-25Antibody or antigen-binding fragment thereof that specifically recognizes B cell malignancies, chimeric antigen receptor comprising same, and uses thereof
#6 | 2020-12-10 ✅ Patent 11,534,462 granted on 2022-12-27Antibody or antigen binding fragment thereof for specifically recognizing B cell malignancy, chimeric antigen receptor comprising same and use thereof
#7 | 2019-08-08 ✅ Patent 10,465,008 granted on 2019-11-05Antibodies against vascular endothelial growth factor receptor 2 (VEGFR2), encoding nucleic acid molecules and methods for treating an angiogenesis-related disease
#8 | 2019-05-23 ✅ Patent 11,248,059 granted on 2022-02-15Antibody having improved stability and specifically binding to HER2
#9 | 2017-05-11 ✅ Patent 10,633,423 granted on 2020-04-28IL-6-binding polypeptide complex
#10 | 2016-02-25 ✅ Patent 10,174,116 granted on 2019-01-08Antibody specifically binding to HER2
Also check out ABCLON INC.'s (Seoul, South Korea) applicant profile with 12 patent applications submitted.
105535 ⎘